Table 1 Distribution of International Classification of Primary Care (ICPC) codes among patients with ≥ 1 code (N = 57,041)
ICPC codes | Disease entity | Reasons for exclusion | number | % |
|---|---|---|---|---|
K87 | Complicated hypertension | The presence of unknown complications may favor or preclude prescription of a particular drug class | 3310 | 5.8% |
T90 | Diabetes Mellitus | Favors the choice of ACEIs | 15560 | 27.3% |
T901 | Impaired glucose tolerance | 353 | 0.6% | |
T92 | Gout | Contraindication of thiazide diuretics | 635 | 1.1% |
T93 | Lipid disorders | Favor the exclusion of thiazide diuretics and β-blockers | 1186 | 2.1% |
K90 | Stroke/cerebrovascular accident | Favor the choice of β-blockers | 1920 | 3.4% |
K91 | Cerebrovascular disease | 130 | 0.2% | |
K74 | Ischemic Heart Disease with angina | 348 | 0.6% | |
K76 | Ischemic Heart Disease without angina | 1099 | 1.9% | |
K75 | Acute Myocardial Infarction | 213 | 0.4% | |
K77 | Heart Failure | Favor the choice of ACEIs | 794 | 1.4% |
K84 | Heart Disease, other | Favor the choice of β-blockers or ACEIs | 168 | 0.3% |
K99 | Cardiovascular disease, other | 113 | 0.2% | |
R79 | Chronic Bronchitis | Contraindication of β-blockers | 436 | 0.8% |
R95 | Chronic Obstructive Pulmonary Disease | 2199 | 3.9% | |
R96 | Asthma | 1083 | 1.9% | |
U14 | Kidney symptoms/complaints | Either favor or a contraindication of ACEIs | 312 | 0.5% |
U88 | Glomerulonephritis/nephrosis | 36 | 0.1% | |
Y85 | Benign Prostatic Hypertrophy | Favor the prescription of α-blockers | 2917 | 5.1% |
U78 | Benign Neoplasm Urinary Tract | 30 | 0.1% | |
Y79 | Benign/unspecified neoplasm, male genital | 1 | 0.0% |